Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

January 21, 2022
Open Access

Toward a Multimodal Computer-Aided Diagnostic Tool for Alzheimer's Disease Conversion.

Frontiers in Neuroscience
Danilo PenaAlzheimer’s Disease Neuroimaging Initiative
January 21, 2022

Clinical Deep Phenotyping of ABCA7 Mutation Carriers.

Neurology. Genetics
Alana S CampbellNilüfer Ertekin-Taner
January 21, 2022
Open Access

Dental Care of Patients With Dementia: A Survey on Practice Equipment, Training, and Dental Treatment.

Frontiers in Oral Health
Sophie SchaperMichael Belz
January 21, 2022

Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Sylvie BellevilleMAPT/DSA group
January 21, 2022

Fading memories in aging and neurodegeneration: Is p75 neurotrophin receptor a culprit?

Ageing Research Reviews
Lik-Wei WongSreedharan Sajikumar
January 21, 2022

A new paradigm in sarcopenia: Cognitive impairment caused by imbalanced myokine secretion and vascular dysfunction.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Danbi JoJuhyun Song
January 21, 2022

The Alzheimer's disease drug candidate J147 decreases blood plasma fatty acid levels via modulation of AMPK/ACC1 signaling in the liver.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Devin KepchiaPamela Maher
January 20, 2022

Prognostic Factors for Cervical Spinal Cord Injury Without Major Bone Injury in Elderly Patients.

Journal of Neurotrauma
Hideaki NakajimaSatoshi Kato
January 20, 2022

Association of small vessel disease with tau pathology.

Acta Neuropathologica
Alifiya KapasiJulie A Schneider
January 19, 2022

Progranulin as a therapeutic target in neurodegenerative diseases.

Trends in Pharmacological Sciences
Herve RhinnArnon Rosenthal
January 19, 2022

Long-term neurocognitive, psychological, and return to work outcomes in meningioma patients.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Angela SekelyKim Edelstein
January 17, 2022

Caring Together: Trajectories of Paid and Family Caregiving Support to Those Living in the Community with Dementia.

The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
Jennifer M ReckreyKatherine A Ornstein

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

© 2022 Meta ULC. All rights reserved